Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Double-blind, Placebo-controlled, Randomized, 1-month Clinical Trial of Immunoxel Combined With Anti-TB Therapy Versus Anti-TB Therapy With Placebo

NCT01061593 is registered in ClinicalTrials.gov with Lisichansk Regional Tuberculosis Dispensary as lead sponsor.

NCT NCT01061593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01061593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Double-blind, Placebo-controlled, Randomized, 1-month Clinical Trial of Immunoxel Combined With Anti-TB Therapy Versus Anti-TB Therapy With Placebo
Lead sponsor
Lisichansk Regional Tuberculosis Dispensary
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
April 30, 2015
Enrollment
269 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, tuberculosis